ETF Battles: ARKG Vs. VHT - Which Healthcare ETF Is The Better Opportunity?

(Video length 00:13:12)

Are you ready to rumble? Season II of ETF Battles is in full swing and in this episode, you'll watch the ARK Genomic Revolution Multi-Sector ETF (ARKG) vs. the Vanguard Healthcare Index ETF (VHT). As the healthcare sector innovates with CRISPR, Covid-19 vaccines, DNA sequencing, stem cell research, and other therapies, which healthcare ETF is better positioned for future growth?

Keep in mind the Vanguard ETF (VHT) is indexed while the ARK ETF (ARKG) is actively managed. And while they both invest in the same industry sector, they do it very differently.

Ron DeLegge referees this audience requested matchup with guest judges Todd Rosenbluth at CFRA Research and Dave Nadig at ETF Trends providing their research insights.

Each ETF is judged against the other in key categories like cost, exposure strategy, performance, and a mystery category. Find out who wins the battle.

Disclaimer: Ron DeLegge has analyzed and graded more than $125 million with his Portfolio Report Card grading system. Does ...

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.